UBS Group’s iPath Inverse S&P 500 VIX Short-Term Futures IVOP Stock Holding History

UBS Group’s Portfolio IVOP Stock Details IVOP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-860	Closed	-$33K	–	8467
2016 Q4	$33K	Hold	860	–	–	﹤0.01%	6179
2016 Q3	$16K	Hold	860	–	–	﹤0.01%	6504
2016 Q2	$31K	Hold	860	–	–	﹤0.01%	5924
2016 Q1	$33K	Sell	860 -230	-21%	-$8.72K	﹤0.01%	5831
2015 Q4	$41K	Hold	1,090	–	–	﹤0.01%	6017
2015 Q3	$41K	Hold	1,090	–	–	﹤0.01%	6016
2015 Q2	$40K	Sell	1,090 -100	-8%	-$3.82K	﹤0.01%	6209
2015 Q1	$45K	Hold	1,190	–	–	﹤0.01%	6171
2014 Q4	$45K	Buy	+1,190	New	+$45.3K	﹤0.01%	6640

Other funds holding IVOP

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group's IVOP Position: Q1 2017 in Review

UBS Group sold out of iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) in Q1 2017, closing a stake of 860 shares — an estimated $33K sold.

UBS Group first reported a position in IVOP in Q4 2014 and held it in 9 quarters. The position peaked at $45K in Q1 2015. 2 funds tracked by Wall St. Rank hold IVOP as of Q1 2017.

UBS Group reported no remaining iPath Inverse S&P 500 VIX Short-Term Futures position as of Q1 2017 after selling out during the quarter.
UBS Group sold 860 iPath Inverse S&P 500 VIX Short-Term Futures shares in Q1 2017, an estimated $33K.
UBS Group first reported a position in iPath Inverse S&P 500 VIX Short-Term Futures in Q4 2014 and held it in 9 quarters.
UBS Group's iPath Inverse S&P 500 VIX Short-Term Futures position peaked at $45K in Q1 2015.
2 funds tracked by Wall St. Rank held iPath Inverse S&P 500 VIX Short-Term Futures as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.